<?xml version="1.0" encoding="UTF-8"?>
<p>The frequency at which fever presents as a symptom is another impediment to successful screening. In the current COVID-19 outbreak, many of those infected are largely asymptomatic and only 73% have exhibited a fever;
 <xref rid="r3" ref-type="bibr">
  <sup>3</sup>
 </xref> in 2009, only half of H1N1 outbreak cases had temperatures of 
 <inline-formula>
  <math id="math299">
   <mrow>
    <mo form="prefix">≥</mo>
    <mn>37.8</mn>
    <mo>°</mo>
    <mi mathvariant="normal">C</mi>
   </mrow>
  </math>
 </inline-formula>;
 <xref rid="r8" ref-type="bibr">
  <sup>8</sup>
 </xref> and a 2011 study indicated that none of the 30 subjects identified as being flu-infected had a temperature of 37.8°C or greater, and only two had a temperature of 37.5°C.
 <xref rid="r20" ref-type="bibr">
  <sup>20</sup>
 </xref> Therefore, while IRT-based screening can detect individuals with elevated body temperature, it is not a viable stand-alone tool for screening for individuals infected with specific diseases.
 <xref rid="r49" ref-type="bibr">
  <sup>49</sup>
 </xref> It may play an adjunct role along with other screening evaluations. Since fever is only one common symptom of infectious disease, an effective screening process should include evaluation of a range of symptoms.
 <xref rid="r3" ref-type="bibr">
  <sup>3</sup>
 </xref>
 <sup>,</sup>
 <xref rid="r7" ref-type="bibr">
  <sup>7</sup>
 </xref>
 <sup>,</sup>
 <xref rid="r8" ref-type="bibr">
  <sup>8</sup>
 </xref> The future development of an integrative screening system may include thermography along with other optical imaging approaches for evaluation of vital signs, such as pulse rate and respiratory rate, and other physiological parameters.
 <xref rid="r8" ref-type="bibr">
  <sup>8</sup>
 </xref>
</p>
